Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Author Correction: Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial.
Houot R, Bachy E, Cartron G, Gros FX, Morschhauser F, Oberic L, Gastinne T, Feugier P, Duléry R, Thieblemont C, Joris M, Jardin F, Choquet S, Casasnovas O, Brisou G, Cheminant M, Bay JO, Gutierrez FL, Menard C, Tarte K, Delfau MH, Portugues C, Itti E, Palard-Novello X, Blanc-Durand P, Al Tabaa Y, Bailly C, Laurent C, Lemonnier F. Houot R, et al. Among authors: blanc durand p. Nat Med. 2024 Jul;30(7):2089. doi: 10.1038/s41591-024-03053-z. Nat Med. 2024. PMID: 38745012 Free PMC article. No abstract available.
Prognostic Value of 18F-FDG PET Radiomics Features at Baseline in PET-Guided Consolidation Strategy in Diffuse Large B-Cell Lymphoma: A Machine-Learning Analysis from the GAINED Study.
Carlier T, Frécon G, Mateus D, Rizkallah M, Kraeber-Bodéré F, Kanoun S, Blanc-Durand P, Itti E, Le Gouill S, Casasnovas RO, Bodet-Milin C, Bailly C. Carlier T, et al. Among authors: blanc durand p. J Nucl Med. 2024 Jan 2;65(1):156-162. doi: 10.2967/jnumed.123.265872. J Nucl Med. 2024. PMID: 37945379
Publisher Correction: Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial.
Houot R, Bachy E, Cartron G, Gros FX, Morschhauser F, Oberic L, Gastinne T, Feugier P, Duléry R, Thieblemont C, Joris M, Jardin F, Choquet S, Casasnovas O, Brisou G, Cheminant M, Bay JO, Gutierrez FL, Menard C, Tarte K, Delfau MH, Portugues C, Itti E, Palard-Novello X, Blanc-Durand P, Al Tabaa Y, Bailly C, Laurent C, Lemonnier F. Houot R, et al. Among authors: blanc durand p. Nat Med. 2023 Oct;29(10):2665. doi: 10.1038/s41591-023-02624-w. Nat Med. 2023. PMID: 37814064 Free PMC article. No abstract available.
Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial.
Houot R, Bachy E, Cartron G, Gros FX, Morschhauser F, Oberic L, Gastinne T, Feugier P, Duléry R, Thieblemont C, Joris M, Jardin F, Choquet S, Casasnovas O, Brisou G, Cheminant M, Bay JO, Gutierrez FL, Menard C, Tarte K, Delfau MH, Portugues C, Itti E, Palard-Novello X, Blanc-Durand P, Al Tabaa Y, Bailly C, Laurent C, Lemonnier F. Houot R, et al. Among authors: blanc durand p. Nat Med. 2023 Oct;29(10):2593-2601. doi: 10.1038/s41591-023-02572-5. Epub 2023 Sep 14. Nat Med. 2023. PMID: 37710005 Free PMC article. Clinical Trial.
[18F]DCFPyL PET/CT versus [18F]fluoromethylcholine PET/CT in Biochemical Recurrence of Prostate Cancer (PYTHON): a prospective, open label, cross-over, comparative study.
Oprea-Lager DE, Gontier E, García-Cañamaque L, Gauthé M, Olivier P, Mitjavila M, Tamayo P, Robin P, García Vicente AM, Bouyeure AC, Bailliez A, Rodríguez-Fernández A, Mahmoud SB, Vallejo-Casas JA, Maksud P, Merlin C, Blanc-Durand P, Drouet C, Tissot H, Vierasu I, Vander Borght T, Boos E, Chossat F, Hodolic M, Rousseau C. Oprea-Lager DE, et al. Among authors: blanc durand p. Eur J Nucl Med Mol Imaging. 2023 Sep;50(11):3439-3451. doi: 10.1007/s00259-023-06301-5. Epub 2023 Jun 21. Eur J Nucl Med Mol Imaging. 2023. PMID: 37341747 Free PMC article. Clinical Trial.
Deep Learning on Bone Scintigraphy to Detect Abnormal Cardiac Uptake at Risk of Cardiac Amyloidosis.
Delbarre MA, Girardon F, Roquette L, Blanc-Durand P, Hubaut MA, Hachulla É, Semah F, Huglo D, Garcelon N, Marchal E, El Esper I, Tribouilloy C, Lamblin N, Duhaut P, Schmidt J, Itti E, Damy T. Delbarre MA, et al. Among authors: blanc durand p. JACC Cardiovasc Imaging. 2023 Aug;16(8):1085-1095. doi: 10.1016/j.jcmg.2023.01.014. Epub 2023 Apr 12. JACC Cardiovasc Imaging. 2023. PMID: 37227330 Free article.
Baseline circulating tumour DNA and total metabolic tumour volume as early outcome predictors in aggressive large B-cell lymphoma. A real-world 112-patient cohort.
Le Goff E, Blanc-Durand P, Roulin L, Lafont C, Loyaux R, MBoumbae DL, Benmaad I, Claudel A, Poullot E, Robe C, Gricourt G, Aissat A, Copie-Bergman C, Lemonnier F, Gaulard P, Itti E, Haioun C, Delfau-Larue MH. Le Goff E, et al. Among authors: blanc durand p. Br J Haematol. 2023 Jul;202(1):54-64. doi: 10.1111/bjh.18809. Epub 2023 Apr 10. Br J Haematol. 2023. PMID: 37038217
Is There a Role of Artificial Intelligence in Preclinical Imaging?
Küper A, Blanc-Durand P, Gafita A, Kersting D, Fendler WP, Seibold C, Moraitis A, Lückerath K, James ML, Seifert R. Küper A, et al. Among authors: blanc durand p. Semin Nucl Med. 2023 Sep;53(5):687-693. doi: 10.1053/j.semnuclmed.2023.03.003. Epub 2023 Apr 8. Semin Nucl Med. 2023. PMID: 37037684 Review.
IgG4-related disease and small lymphocytic lymphoma.
Moktefi A, Mulé S, Joher N, Blanc-Durand P, Oniszczuk J, Matignon M, Le Bras F, El Karoui K. Moktefi A, et al. Among authors: blanc durand p. QJM. 2023 Jul 28;116(7):523-524. doi: 10.1093/qjmed/hcad019. QJM. 2023. PMID: 36749002 No abstract available.
32 results